Welcome to our dedicated page for Aflac SEC filings (Ticker: AFL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aflac Incorporated (NYSE: AFL) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Fortune 500 insurer in the direct life and supplemental health insurance industry, Aflac uses its filings to report financial results, risk factors, capital structure changes and significant events affecting its U.S. and Japan operations.
Investors can review Aflac’s periodic reports, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, to understand segment performance for Aflac U.S. and Aflac Japan, trends in net earned premiums, adjusted earnings, investment income and capital position. These filings also discuss exposure to interest rate movements, foreign currency fluctuations in the yen/dollar exchange rate, regulatory developments and other risks that the company identifies as material to its business.
Current reports on Form 8-K offer more timely updates on specific events. Recent 8-K filings have covered quarterly financial results, supplemental earnings materials, investor presentations and a cybersecurity incident involving unauthorized access to Aflac’s network. Other 8-Ks describe financing arrangements, including contingent funding facilities and pre-capitalized trust securities that give Aflac the right to issue senior notes under defined conditions.
On Stock Titan, these filings are supplemented with AI-powered summaries that explain key points in clear language, helping users interpret complex sections on financial condition, liquidity, capital management and risk disclosures. The platform also surfaces relevant forms such as Form 4 insider transaction reports, proxy materials on executive and director matters, and other documents that can be important for evaluating governance and insider activity.
By using this page, readers can track Aflac’s real-time filing activity from EDGAR, quickly grasp the implications of lengthy documents through AI-generated highlights, and reference the underlying full-text filings for deeper analysis of AFL’s regulatory and financial reporting history.
Aflac Inc. (AFL) director Joseph L. Moskowitz reported an insider transaction involving company stock. On 11/17/2025, he exercised a director stock option for 2,000 shares of common stock at an exercise price of $44.59 per share, increasing his direct share holdings.
On the same date, he reported a sale of 786 shares of Aflac common stock at a price of $113.745 per share. After these transactions, he directly beneficially owned 24,829 shares of Aflac common stock and held 20,303 derivative securities (stock options) directly.
Aflac Incorporated reported an insider transaction by its Sr. Executive Vice President, Audrey B. Tillman. On 11/14/2025, she exercised an employee stock option to buy 3,452 shares of common stock at $28.965 per share and on the same date sold 3,452 shares at $115.10 per share. After these transactions, she directly holds 230,688 shares of Aflac common stock, plus 17,899 shares through a 401(k) plan and 9 shares held by her children. Following the option exercise, she continues to hold 15,862 employee stock options.
Aflac Incorporated (AFL) shareholder filed a Form 144 notice to sell 15,862 shares of common stock. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,776,544.00 and 524,113,917 common shares outstanding noted for context.
The shares to be sold were acquired on 11/18/2025 through the exercise of an option originally granted on 02/09/2016, paid for in cash. The filing also reports that the same seller disposed of 3,452 common shares on 11/14/2025 for gross proceeds of $397,325.20 during the prior three months.
A holder of AFL common stock has filed a Form 144 notice indicating an intent to sell 786 common shares through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 11/17/2025. The filing lists an aggregate market value of 114,000.00 for a prior sale of 1,000 shares on 11/07/2025 and shows 524,113,917 common shares outstanding for the issuer.
The shares to be sold were acquired via a stock option granted on 05/07/2018 and paid for in cash on 11/17/2025. The seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations, as required by the Form 144 certification.
Aflac (AFL) filed a Form 144 indicating a proposed sale of restricted or control securities under Rule 144. The filer plans to sell 3,452 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, reflecting an aggregate market value of $397,325.20. The shares were acquired via stock options granted on 02/09/2016 and exercised for cash on 11/14/2025. Aflac had 524,113,917 shares outstanding at the time listed in the notice. Form 144 is a notice of intent and does not guarantee that a sale will occur.
Aflac Incorporated (AFL) reported an insider transaction by its Sr. EVP and CFO, Max K. Broden. On 11/10/2025, he exercised employee stock options (transaction code M) to acquire 4,668 shares of common stock at an exercise price of
Following this transaction, his beneficial ownership stands at 135,021 shares held directly and 339 shares held indirectly through his spouse. The options were part of a grant that vested in three tranches during 2018–2020 and carry an expiration date of 06/26/2027.
Aflac (AFL) insider filing: Senior Executive Vice President Audrey B. Tillman reported a bona fide gift of 26,970 shares of Aflac common stock on 11/07/2025 (Transaction Code G) at a reported price of $0.
After the transaction, she beneficially owned 230,688 shares directly. She also reported 17,899 shares held indirectly through a 401(k) Plan and 9 shares held indirectly by children.
Aflac Inc. (AFL) director Joseph L. Moskowitz reported an open‑market sale of 1,000 shares of common stock at $114 on 11/07/2025.
Following the sale, he beneficially owns 23,615 shares, held directly. The transaction was executed pursuant to a Rule 10b5‑1 trading plan adopted on 12/04/2024.
Aflac (AFL) reported an insider stock sale by EVP, COO & CFO, Aflac U.S., Frederic Simard. On 11/06/2025, he sold 1,722 shares of common stock at $112.50 per share. Following the transaction, he beneficially owns 1,364 shares directly and 589 shares indirectly through a 401(k) plan.
Aflac (AFL) received a Form 144 notice for a proposed sale of 1,000 common shares with an aggregate market value of $114,000. The filing lists Fidelity Brokerage Services LLC as broker and the NYSE as the exchange, with an approximate sale date of 11/07/2025.
The shares were acquired through restricted stock vesting from the issuer on 05/03/2023 (121), 05/19/2023 (478), and 05/01/2024 (401). Shares outstanding were 524,113,917. In the past three months, Joseph Moskowitz sold 1,000 shares on 08/08/2025 for $102,570.
FAQ
What is the current stock price of Aflac (AFL)?
What is the market cap of Aflac (AFL)?
